Lv1
40 积分 2025-07-31 加入
PT1.07.01 IASLC Multidisciplinary Recommendations for Pathological Response Evaluation of Resected Lymph Nodes After Neoadjuvant Therapy in NSCLC
1天前
求助中
OA16.04 Prognostic Value of Residual Viable Tumor in Lymph Nodes of Non-Small Cell Lung Cancer After Neoadjuvant Chemoimmunotherapy
1天前
求助中
Comparison of 10-year Survival Outcomes between CT Surveillance and Surgery for Ground-Glass Nodules
11天前
已完结
780. NEOADJUVANT IMMUNOTHERAPY COMBINED WITH CHEMORADIOTHERAPY VS NEOADJUVANT CHEMORADIOTHERAPY FOR LOCALLY ADVANCED ESOPHAGEAL CARCINOMA (CSTAGEII-III): A MULTI-CENTER PROSPECTIVE RANDOMIZED CLINICAL TRIAL (ICROSS)
18天前
已完结
A randomized controlled study on perioperative treatment of esophageal squamous cell carcinoma with camrelizumab combined with nab-paclitaxel and cisplatin
18天前
已关闭
皖公网安备34019202002308
